Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8538)
All Articles published online
|
Publishing Process of This Article
|
May 14, 2014 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shaker M, Tabbaa A, Albeldawi M, Alkhouri N. Liver transplantation for nonalcoholic fatty liver disease: New challenges and new opportunities. World J Gastroenterol 2014; 20(18): 5320-5330 [PMID: 24833862 DOI: 10.3748/wjg.v20.i18.5320] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i18/5320.htm |
| Number | Citing Articles |
| 1 |
Qian Yu, Yann-yin Lee, Zheng-yun Xia, Emily C. Liong, Jia Xiao, George L. Tipoe. S-allylmercaptocysteine improves nonalcoholic steatohepatitis by enhancing AHR/NRF2-mediated drug metabolising enzymes and reducing NF-κB/IκBα and NLRP3/6-mediated inflammation. European Journal of Nutrition 2021; 60(2): 961 doi: 10.1007/s00394-020-02305-1
|
| 2 |
E. Ramos-Tovar, P. Muriel. Liver Pathophysiology. 2017; : 743 doi: 10.1016/B978-0-12-804274-8.00053-9
|
| 3 |
Fumin Li, Christopher Cousineau, Gang Xing, Nancy Raha, Sara Clemens, Melissa Mofikoya, Moo-Young Kim, Jenny Yanhua Zhang. Development and Validation of a Quantitative Ultra Performance LC® Hydrophilic Interaction Liquid Chromatography MS/MS Method to Measure Fructose and Sorbitol in Human Plasma. Bioanalysis 2019; 11(5): 407 doi: 10.4155/bio-2018-0286
|
| 4 |
Karim Gariani, Keir J. Menzies, Dongryeol Ryu, Casey J. Wegner, Xu Wang, Eduardo R. Ropelle, Norman Moullan, Hongbo Zhang, Alessia Perino, Vera Lemos, Bohkyung Kim, Young‐Ki Park, Alessandra Piersigilli, Tho X. Pham, Yue Yang, Chai Siah Ku, Sung I. Koo, Anna Fomitchova, Carlos Cantó, Kristina Schoonjans, Anthony A. Sauve, Ji‐Young Lee, Johan Auwerx. Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice. Hepatology 2016; 63(4): 1190 doi: 10.1002/hep.28245
|
| 5 |
Marta Iruarrizaga-Lejarreta, Enara Arretxe, Cristina Alonso. Using metabolomics to develop precision medicine strategies to treat nonalcoholic steatohepatitis. Expert Review of Precision Medicine and Drug Development 2019; 4(5): 283 doi: 10.1080/23808993.2019.1685379
|
| 6 |
Péter Jenö Hegyi, Alexandra Soós, Péter Hegyi, Zsolt Szakács, Lilla Hanák, Szilárd Váncsa, Klementina Ocskay, Erika Pétervári, Márta Balaskó, Bálint Eröss, Gabriella Pár. Pre-transplant Sarcopenic Obesity Worsens the Survival After Liver Transplantation: A Meta-Analysis and a Systematic Review. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.599434
|
| 7 |
Paul N. Brennan, Ahmed M. Elsharkawy, Timothy J. Kendall, Rohit Loomba, Derek A. Mann, Jonathan A. Fallowfield. Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach. Nature Reviews Gastroenterology & Hepatology 2023; 20(10): 679 doi: 10.1038/s41575-023-00796-x
|
| 8 |
Jacob Beiriger, Kashyap Chauhan, Adnan Khan, Taha Shahzad, Natalia Salinas Parra, Peter Zhang, Sarah Chen, Anh Nguyen, Brian Yan, John Bruckbauer, Dina Halegoua-DeMarzio. Advancements in Understanding and Treating NAFLD: A Comprehensive Review of Metabolic-Associated Fatty Liver Disease and Emerging Therapies. Livers 2023; 3(4): 637 doi: 10.3390/livers3040042
|
| 9 |
Birnur Yılmaz, Özgür Kürşat Şener, Halime Çevik. Shear Wave Velocity results of non-alcoholic fatty liver disease in diabetic patients. Journal of Surgery and Medicine 2018; doi: 10.28982/josam.435189
|
| 10 |
Piper Sandel, Lawrence Ma, Helen Wang, Eric A. Pasman. You Are What You Eat: A Review on Dietary Interventions for Treating Pediatric Nonalcoholic Fatty Liver Disease. Nutrients 2023; 15(15): 3350 doi: 10.3390/nu15153350
|
| 11 |
Marcus Grohmann, Florian Wiede, Garron T. Dodd, Esteban N. Gurzov, Geraldine J. Ooi, Tariq Butt, Aliki A. Rasmiena, Supreet Kaur, Twishi Gulati, Pei K. Goh, Aislinn E. Treloar, Stuart Archer, Wendy A. Brown, Mathias Muller, Matthew J. Watt, Osamu Ohara, Catriona A. McLean, Tony Tiganis. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell 2018; 175(5): 1289 doi: 10.1016/j.cell.2018.09.053
|
| 12 |
Yixing Li, Zupeng Luo, Xilong Wu, Jun Zhu, Kai Yu, Yi Jin, Zhiwang Zhang, Shuhong Zhao, Lei Zhou. Proteomic Analyses of Cysteine Redox in High-Fat-Fed and Fasted Mouse Livers: Implications for Liver Metabolic Homeostasis. Journal of Proteome Research 2018; 17(1): 129 doi: 10.1021/acs.jproteome.7b00431
|
| 13 |
Seokwon Lee, Younglae Jung, Youngtae Bae, Sung Pil Yun, Suk Kim, Hongjae Jo, Hyung-Il Seo. Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in Breast Cancer Patients. Tumori Journal 2017; 103(2): 187 doi: 10.5301/tj.5000536
|
| 14 |
Everton Cazzo, Laísa Simakawa Jimenez, Fábio de Felice Gallo, José Carlos Pareja, Elinton Adami Chaim. Influence of type 2 diabetes mellitus on liver histology among morbidly obese individuals. A cross-sectional study. Sao Paulo Medical Journal 2016; 134(1): 79 doi: 10.1590/1516-3180.2015.01652409
|
| 15 |
Everton Cazzo, José Carlos Pareja, Elinton Adami Chaim. Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review. Sao Paulo Medical Journal 2017; 135(3): 277 doi: 10.1590/1516-3180.2016.0306311216
|
| 16 |
Kevin M. Hart, Thomas Fabre, Joshua C. Sciurba, Richard L. Gieseck, Lee A. Borthwick, Kevin M. Vannella, Thomas H. Acciani, Rafael de Queiroz Prado, Robert W. Thompson, Sandra White, Genevieve Soucy, Marc Bilodeau, Thirumalai R. Ramalingam, Joseph R. Arron, Naglaa H. Shoukry, Thomas A. Wynn. Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β. Science Translational Medicine 2017; 9(396) doi: 10.1126/scitranslmed.aal3694
|
| 17 |
Jelena Popov, Tijana Despot, David Avelar Rodriguez, Irfan Khan, Eugene Mech, Mahrukh Khan, Milan Bojadzija, Nikhil Pai. Implications of Microbiota and Immune System in Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease. Nutrients 2024; 16(11): 1668 doi: 10.3390/nu16111668
|
| 18 |
Letícia BALTIERI, Elinton Adami CHAIM, Felipe David Mendonça CHAIM, Murillo Pimentel UTRINI, Martinho Antonio GESTIC, Everton CAZZO. CORRELATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE FEATURES AND LEVELS OF ADIPOKINES AND INFLAMMATORY CYTOKINES AMONG MORBIDLY OBESE INDIVIDUALS. Arquivos de Gastroenterologia 2018; 55(3): 247 doi: 10.1590/s0004-2803.201800000-62
|
| 19 |
Natalia Pydyn, Katarzyna Miękus, Jolanta Jura, Jerzy Kotlinowski. New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis. Pharmacological Reports 2020; 72(1): 1 doi: 10.1007/s43440-019-00020-1
|
| 20 |
Eva M. Dobrindt, Laura Allex, Akylbek Saipbaev, Robert Öllinger, Wenzel Schöning, Johann Pratschke, Dennis Eurich. Association between obesity after liver transplantation and steatosis, inflammation, and fibrosis of the graft. Clinical Transplantation 2020; 34(12) doi: 10.1111/ctr.14093
|
| 21 |
Christian von Loeffelholz, Johannes Roth, Sina Coldewey, Andreas Birkenfeld. The Role of Physical Activity in Nonalcoholic and Metabolic Dysfunction Associated Fatty Liver Disease. Biomedicines 2021; 9(12): 1853 doi: 10.3390/biomedicines9121853
|
| 22 |
Srinevas K. Reddy, David A. Geller. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 1065 doi: 10.1016/B978-0-323-34062-5.00071-6
|
| 23 |
Jadine Scragg, Kate Hallsworth, Guy Taylor, Sophie Cassidy, Laura Haigh, Marie Boyle, Quentin Anstee, Stuart McPherson, Leah Avery. Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease. BMJ Open Gastroenterology 2021; 8(1): e000678 doi: 10.1136/bmjgast-2021-000678
|
| 24 |
Yangyang Hui, Binxin Cui, Xiaoyu Wang, Mingyu Sun, Yifan Li, Wanting Yang, Gaoyue Guo, Lihong Mao, Zihan Yu, Xiaofei Fan, Chao Sun. Sarcopenic obesity in liver disease: Handling both sides of the penny. Portal Hypertension & Cirrhosis 2022; 1(1): 42 doi: 10.1002/poh2.10
|
| 25 |
Maria Styliani Kalogirou, Olga Giouleme. Growing challenge of post-liver transplantation non-alcoholic fatty liver disease. World Journal of Transplantation 2022; 12(9): 281-287 doi: 10.5500/wjt.v12.i9.281
|
| 26 |
Pauline Verhaegh, Roisin Bavalia, Bjorn Winkens, Ad Masclee, Daisy Jonkers, Ger Koek. Noninvasive Tests Do Not Accurately Differentiate Nonalcoholic Steatohepatitis From Simple Steatosis: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2018; 16(6): 837 doi: 10.1016/j.cgh.2017.08.024
|
| 27 |
Della Corte Claudia, Antonella Mosca, Arianna Alterio, Donatella Comparcola, Francesca Ferretti, Valerio Nobili. Pediatric Obesity. Contemporary Endocrinology 2018; : 451 doi: 10.1007/978-3-319-68192-4_26
|
| 28 |
Julio Plaza-Díaz, Patricio Solis-Urra, Jerónimo Aragón-Vela, Fernando Rodríguez-Rodríguez, Jorge Olivares-Arancibia, Ana I. Álvarez-Mercado. Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis. Biomedicines 2021; 9(2): 145 doi: 10.3390/biomedicines9020145
|
| 29 |
Sonja Beckmann, Patrizia Künzler-Heule, Kajetan Kabut, Oliver Mauthner. The Main Thing is to be Alive—Exploring Patients’ Experiences With Weight Gain After Liver Transplantation: A Qualitative Study. Transplant International 2022; 35 doi: 10.3389/ti.2022.10256
|
| 30 |
Akemi Ichikawa, Daiki Miki, C. Nelson Hayes, Yuji Teraoka, Hikaru Nakahara, Chise Tateno, Yuji Ishida, Kazuaki Chayama, Shiro Oka. Multi-omics analysis of a fatty liver model using human hepatocyte chimeric mice. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-53890-8
|
| 31 |
Peng Shi, Junru Chen, Jinke Lin, Lurong Zhang. High-throughput fat quantifications of hematoxylin-eosin stained liver histopathological images based on pixel-wise clustering. Science China Information Sciences 2017; 60(9) doi: 10.1007/s11432-016-9018-7
|
| 32 |
Luis Calzadilla‐Bertot, Gary P. Jeffrey, Bryon Jacques, Geoffrey McCaughan, Michael Crawford, Peter Angus, Robert Jones, Edward Gane, Stephen Munn, Graeme Macdonald, Jonathan Fawcett, Alan Wigg, John Chen, Michael Fink, Leon A. Adams. Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New Zealand. Liver Transplantation 2019; 25(1): 25 doi: 10.1002/lt.25361
|
| 33 |
Namrata Patel, Valentina Discepolo, Nour Asfour, Ruba K. Azzam. Preparedness of Residents to Manage Pediatric Nonalcoholic Fatty Liver Disease: A National Survey. JPGN Reports 2022; 3(3): e219 doi: 10.1097/PG9.0000000000000219
|
| 34 |
Jie Li, Guocai Liu, Feng Zhang, Zhiwen Zhang, Yuqiao Xu, Qing Li. Role of glycoprotein 78 and cidec in hepatic steatosis. Molecular Medicine Reports 2017; 16(2): 1871 doi: 10.3892/mmr.2017.6834
|
| 35 |
Lin Fan, Zhen Fu, Yan Xiong, Shaojun Ye, Yanfeng Wang, Guizhu Peng, Qifa Ye. Double‑lobectomy in a steatotic liver transplantation rat model. Experimental and Therapeutic Medicine 2021; 21(3) doi: 10.3892/etm.2021.9687
|
| 36 |
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities,
and Management of Non-alcoholic Fatty Liver Disorder. Current Drug Therapy 2024; 19(1): 20 doi: 10.2174/1574885518666230417111247
|
| 37 |
Gang Chen, Dongsheng Yu, Xue Nian, Junyi Liu, Ronald J. Koenig, Bin Xu, Liang Sheng. LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL). Scientific Reports 2016; 6(1) doi: 10.1038/srep35531
|
| 38 |
Wen Su, Zhuo Mao, Yiao Liu, Xiaoyan Zhang, Weizhen Zhang, Jan-Ake Gustafsson, Youfei Guan. Role of HSD17B13 in the liver physiology and pathophysiology. Molecular and Cellular Endocrinology 2019; 489: 119 doi: 10.1016/j.mce.2018.10.014
|
| 39 |
FAN PAN, NAISHUN LIAO, YOUSHI ZHENG, YINGCHAO WANG, YUNZHEN GAO, SEN WANG, YI JIANG, XIAOLONG LIU. Intrahepatic transplantation of adipose-derived stem cells attenuates the progression of non-alcoholic fatty liver disease in rats. Molecular Medicine Reports 2015; 12(3): 3725 doi: 10.3892/mmr.2015.3847
|
| 40 |
Liang Liu, Qinling Hu, Huihui Wu, Xiujing Wang, Chao Gao, Guoxun Chen, Ping Yao, Zhiyong Gong, Joan Roselló-Catafau. Dietary DHA/EPA Ratio Changes Fatty Acid Composition and Attenuates Diet‐Induced Accumulation of Lipid in the Liver of ApoE−/− Mice. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/6256802
|
| 41 |
David Uihwan Lee, Ashley Yoo, Sindhura Kolachana, Jaehyun Lee, Reid Ponder, Gregory Hongyuan Fan, Ki Jung Lee, KeeSeok Lee, Kimmy Schuster, Harrison Chou, Hannah Chou, Catherine Sun, Michael Chang, Alex Pu, Nathalie Helen Urrunaga. The impact of macro‐ and micro‐steatosis on the outcomes of patients who undergo liver transplant: Analysis of the UNOS‐STAR database. Liver International 2024; 44(8): 2011 doi: 10.1111/liv.15908
|
| 42 |
Harriet Gaskell, Xiaodong Ge, Natalia Nieto. High‐Mobility Group Box‐1 and Liver Disease. Hepatology Communications 2018; 2(9): 1005 doi: 10.1002/hep4.1223
|
| 43 |
Ajay C Donepudi, Gregory J Smith, Oladimeji Aladelokun, Yoojin Lee, Steven J Toro, Marisa Pfohl, Angela L Slitt, Li Wang, Ji-Young Lee, John D Schuetz, José E Manautou. Lack of Multidrug Resistance-associated Protein 4 Prolongs Partial Hepatectomy-induced Hepatic Steatosis. Toxicological Sciences 2020; 175(2): 301 doi: 10.1093/toxsci/kfaa032
|
| 44 |
Sujal Patel, Shilpa Bawankule, Sourya Acharya, Sunil Kumar. Cytokines and Inflammatory Markers in Nonalcoholic Fatty Liver Disease: A Narrative Review. Journal of the Scientific Society 2023; 50(3): 307 doi: 10.4103/jss.jss_237_22
|
| 45 |
Dongxiao Ding, Guozhu Ye, Yi Lin, Yanyang Lu, Han Zhang, Xu Zhang, Zhenyu Hong, Qiansheng Huang, Yulang Chi, Jinsheng Chen, Sijun Dong. MicroRNA-26a-CD36 signaling pathway: Pivotal role in lipid accumulation in hepatocytes induced by PM2.5 liposoluble extracts. Environmental Pollution 2019; 248: 269 doi: 10.1016/j.envpol.2019.01.112
|
| 46 |
Liyang Wang, MengMeng Xu, Odell D. Jones, Zhongguang Li, Yu Liang, Qiuxia Yu, Jiali Li, Yajun Wu, Xinjuan Lei, Boling He, Huimin Yue, Liqin Xiao, Rong Zhou, Wei Zhang, Xin Zhou, Yuhui Zhang, Joseph L. Bryant, Jianjie Ma, Yingli Liu, Xuehong Xu. Nonalcoholic fatty liver disease experiences accumulation of hepatic liquid crystal associated with increasing lipophagy. Cell & Bioscience 2020; 10(1) doi: 10.1186/s13578-020-00414-2
|
| 47 |
Sara Shojaei Zarghani, Nima Rahimi Kashkooli, Zahra Bagheri, Mahdy Tabatabaei, Mohammad Reza Fattahi, Ali Reza Safarpour. Dietary selenium intake in relation to non-alcoholic fatty liver disease assessed by fatty liver index and hepatic steatosis index; a cross-sectional study on the baseline data of prospective PERSIAN Kavar cohort study.. BMC Endocrine Disorders 2023; 23(1) doi: 10.1186/s12902-023-01307-4
|
| 48 |
Olfa Khalifa, Khalid Ouararhni, Khaoula Errafii, Nehad M. Alajez, Abdelilah Arredouani. Targeted MicroRNA Profiling Reveals That Exendin-4 Modulates the Expression of Several MicroRNAs to Reduce Steatosis in HepG2 Cells. International Journal of Molecular Sciences 2023; 24(14): 11606 doi: 10.3390/ijms241411606
|
| 49 |
Mahsa Miryan, Mitra Darbandi, Mozhgan Moradi, Farid Najafi, Davood Soleimani, Yahya Pasdar. Relationship between the Mediterranean diet and risk of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A cross-sectional analysis of the RaNCD cohort. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1062008
|
| 50 |
Margaret Morrison, Heather Y. Hughes, Susanna Naggie, Wing-Kin Syn. Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern?. Digestive Diseases and Sciences 2019; 64(12): 3394 doi: 10.1007/s10620-019-05861-7
|
| 51 |
Jadine Scragg, Leah Avery, Sophie Cassidy, Guy Taylor, Laura Haigh, Marie Boyle, Michael I. Trenell, Quentin M. Anstee, Stuart McPherson, Kate Hallsworth. Feasibility of a Very Low Calorie Diet to Achieve a Sustainable 10% Weight Loss in Patients With Nonalcoholic Fatty Liver Disease. Clinical and Translational Gastroenterology 2020; 11(9): e00231 doi: 10.14309/ctg.0000000000000231
|
| 52 |
Qi Su, Sun Y. Kim, Funmi Adewale, Ye Zhou, Christina Aldler, Min Ni, Yi Wei, Michael E. Burczynski, Gurinder S. Atwal, Mark W. Sleeman, Andrew J. Murphy, Yurong Xin, Xiping Cheng. Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver. iScience 2021; 24(11): 103233 doi: 10.1016/j.isci.2021.103233
|
| 53 |
Lindsay D. Plank, Kylie Russell. Nutrition in liver transplantation. Current Opinion in Clinical Nutrition and Metabolic Care 2015; 18(5): 501 doi: 10.1097/MCO.0000000000000205
|
| 54 |
Zhipeng Li, Hui Jin, So Young Oh, Geun Eog Ji. Anti-obese effects of two Lactobacilli and two Bifidobacteria on ICR mice fed on a high fat diet. Biochemical and Biophysical Research Communications 2016; 480(2): 222 doi: 10.1016/j.bbrc.2016.10.031
|
| 55 |
André Homeyer, Seddik Hammad, Lars Ole Schwen, Uta Dahmen, Henning Höfener, Yan Gao, Steven Dooley, Andrea Schenk. Focused scores enable reliable discrimination of small differences in steatosis. Diagnostic Pathology 2018; 13(1) doi: 10.1186/s13000-018-0753-5
|
| 56 |
Giuseppina Pisano, Anna L Fracanzani, Lucio Caccamo, Maria F Donato, Silvia Fargion. Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study. World Journal of Gastroenterology 2016; 22(40): 8869-8882 doi: 10.3748/wjg.v22.i40.8869
|
| 57 |
Carolyn Ahlers, Matthew Kappus. Obesity management for the pre–liver transplant and post–liver transplant patient. Clinical Liver Disease 2023; 21(6): 165 doi: 10.1097/CLD.0000000000000039
|
| 58 |
Chongshu Jian, Jiajun Fu, Xu Cheng, Li-Jun Shen, Yan-Xiao Ji, Xiaoming Wang, Shan Pan, Han Tian, Song Tian, Rufang Liao, Kehan Song, Hai-Ping Wang, Xin Zhang, Yibin Wang, Zan Huang, Zhi-Gang She, Xiao-Jing Zhang, Lihua Zhu, Hongliang Li. Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis. Cell Metabolism 2020; 31(5): 892 doi: 10.1016/j.cmet.2020.04.011
|
| 59 |
Mélissa Léveillé, Jennifer L. Estall. Mitochondrial Dysfunction in the Transition from NASH to HCC. Metabolites 2019; 9(10): 233 doi: 10.3390/metabo9100233
|
| 60 |
Huiling Wu, Xi Song, Yuntao Ling, Jin Zhou, Zhen Tao, Yuying Shen. Comprehensive bioinformatics analysis of critical lncRNAs, mRNAs and miRNAs in non‑alcoholic fatty liver disease. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.9931
|
| 61 |
Lili Chen, Qianfei Zhang, Chang Yu, Fang Wang, Xiaoni Kong. Functional roles of CCL5/RANTES in liver disease. Liver Research 2020; 4(1): 28 doi: 10.1016/j.livres.2020.01.002
|
| 62 |
David O. Garcia, Kristin E. Morrill, Melissa Lopez‐Pentecost, Edgar A. Villavicencio, Rosa M. Vogel, Melanie L. Bell, Yann C. Klimentidis, David G. Marrero, Cynthia A. Thomson. Nonalcoholic Fatty Liver Disease and Associated Risk Factors in a Community‐Based Sample of Mexican‐Origin Adults. Hepatology Communications 2022; 6(6): 1322 doi: 10.1002/hep4.1896
|
| 63 |
Everton Cazzo, Martinho Antonio Gestic, Murillo Pimentel Utrini, Felipe David Mendonça Chaim, Francisco Callejas-Neto, José Carlos Pareja, Elinton Adami Chaim. Bariatric surgery in individuals with liver cirrhosis: A narrative review. Revista da Associação Médica Brasileira 2017; 63(2): 190 doi: 10.1590/1806-9282.63.02.190
|
| 64 |
Jie Yan, Yang Yu, Jeon Woong Kang, Zhi Yang Tam, Shuoyu Xu, Eliza Li Shan Fong, Surya Pratap Singh, Ziwei Song, Lisa Tucker‐Kellogg, Peter T. C. So, Hanry Yu. Development of a classification model for non‐alcoholic steatohepatitis (NASH) using confocal Raman micro‐spectroscopy. Journal of Biophotonics 2017; 10(12): 1703 doi: 10.1002/jbio.201600303
|
| 65 |
Diehua Hu, Nadia Primc. Should responsibility be used as a tiebreaker in allocation of deceased donor organs for patients suffering from alcohol-related end-stage liver disease?. Medicine, Health Care and Philosophy 2023; 26(2): 243 doi: 10.1007/s11019-023-10141-3
|
| 66 |
Duc-Hung Pham, Changwen Zhang, Chunyue Yin. Using Zebrafish to Model Liver Diseases-Where Do We Stand?. Current Pathobiology Reports 2017; 5(2): 207 doi: 10.1007/s40139-017-0141-y
|
| 67 |
Mustafa Oruc, Mustafa Emre Gedik, Meral Uner, Elif Ulug, Reyhan Nergiz Unal, Gurcan Gunaydin, Ahmet Bulent Dogrul. Effectiveness of metformin for the reversal of cold-ischemia-induced damage in hepatosteatosis. Clinics and Research in Hepatology and Gastroenterology 2024; 48(4): 102314 doi: 10.1016/j.clinre.2024.102314
|
| 68 |
Ivana Mikolasevic, Lidija Orlic, Irena Hrstic, Sandra Milic. Metabolic syndrome and non‐alcoholic fatty liver disease after liver or kidney transplantation. Hepatology Research 2016; 46(9): 841 doi: 10.1111/hepr.12642
|
| 69 |
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 2016; 65(8): 1109 doi: 10.1016/j.metabol.2016.05.003
|
| 70 |
Han Rae Kim, Colin N. Young. Circumventricular organ‐hypothalamic circuit endoplasmic reticulum stress drives hepatic steatosis during obesity. Obesity 2024; 32(1): 59 doi: 10.1002/oby.23895
|
| 71 |
Antonella Mosca, Silvio Veraldi, Andrea Dellostrologo, Mariateresa Sanseviero, Valerio Nobili. Pediatric Hepatology and Liver Transplantation. 2019; : 279 doi: 10.1007/978-3-319-96400-3_17
|
| 72 |
Fan Lin, Fu Zhen, Xiong Yan, Ye Shaojun, Peng Guizhu, Wang Yanfeng, Ye Qifa. Hypothermic oxygenated perfusion with defatting cocktail further improves steatotic liver grafts in a transplantation rat model. Artificial Organs 2021; 45(9) doi: 10.1111/aor.13976
|
| 73 |
Preethi Chandrasekaran, Ralf Weiskirchen. The Pivotal Role of the Membrane-Bound O-Acyltransferase Domain Containing 7 in Non-Alcoholic Fatty Liver Disease. Livers 2023; 4(1): 1 doi: 10.3390/livers4010001
|
| 74 |
André Homeyer, Patrik Nasr, Christiane Engel, Stergios Kechagias, Peter Lundberg, Mattias Ekstedt, Henning Kost, Nick Weiss, Tim Palmer, Horst Karl Hahn, Darren Treanor, Claes Lundström. Automated quantification of steatosis: agreement with stereological point counting. Diagnostic Pathology 2017; 12(1) doi: 10.1186/s13000-017-0671-y
|
| 75 |
NAISHUN LIAO, FAN PAN, YINGCHAO WANG, YOUSHI ZHENG, BO XU, WENWEI CHEN, YUNZHEN GAO, ZHIXIONG CAI, XIAOLONG LIU, JINGFENG LIU. Adipose tissue-derived stem cells promote the reversion of non-alcoholic fatty liver disease: An in vivo study. International Journal of Molecular Medicine 2016; 37(5): 1389 doi: 10.3892/ijmm.2016.2528
|
| 76 |
Manuel Manzano, Maria D. Giron, Rafael Salto, Jose D. Vilchez, Francisco J. Reche-Perez, Elena Cabrera, Azahara Linares-Pérez, Julio Plaza-Díaz, Francisco Javier Ruiz-Ojeda, Angel Gil, Ricardo Rueda, Jose M. López-Pedrosa. Quality More Than Quantity: The Use of Carbohydrates in High-Fat Diets to Tackle Obesity in Growing Rats. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.809865
|
| 77 |
Emma Hymel, Elizabeth Vlock, Kurt W. Fisher, Paraskevi A. Farazi, Marcia B. Aguila. Differential progression of unhealthy diet-induced hepatocellular carcinoma in obese and non-obese mice. PLOS ONE 2022; 17(8): e0272623 doi: 10.1371/journal.pone.0272623
|
| 78 |
Prakash I. Gangashetty, Babu N. Motagi, Ramachandra Pavan, Mallikarjun B. Roodagi. Advances in Plant Breeding Strategies: Agronomic, Abiotic and Biotic Stress Traits. 2016; : 35 doi: 10.1007/978-3-319-22518-0_2
|
| 79 |
Katia P. Souto, Nelson G. Meinhardt, Maurício J. Ramos, Jane M. Ulbrich-Kulkzynski, Airton T. Stein, Daniel C. Damin. Nonalcoholic fatty liver disease in patients with different baseline glucose status undergoing bariatric surgery: analysis of intraoperative liver biopsies and literature review. Surgery for Obesity and Related Diseases 2018; 14(1): 66 doi: 10.1016/j.soard.2017.09.527
|
| 80 |
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes. Cancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
|
| 81 |
Ysabel C. Ilagan-Ying, Bubu A. Banini, Albert Do, Robert Lam, Joseph K. Lim. Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice. Current Gastroenterology Reports 2023; 25(10): 213 doi: 10.1007/s11894-023-00883-8
|
| 82 |
Gregory H. Norris, Christopher N. Blesso. Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease. Nutrition Reviews 2017; 75(4): 274 doi: 10.1093/nutrit/nux004
|
| 83 |
Sunjae Lee, Cheng Zhang, Zhengtao Liu, Martina Klevstig, Bani Mukhopadhyay, Mattias Bergentall, Resat Cinar, Marcus Ståhlman, Natasha Sikanic, Joshua K Park, Sumit Deshmukh, Azadeh M Harzandi, Tim Kuijpers, Morten Grøtli, Simon J Elsässer, Brian D Piening, Michael Snyder, Ulf Smith, Jens Nielsen, Fredrik Bäckhed, George Kunos, Mathias Uhlen, Jan Boren, Adil Mardinoglu. Network analyses identify liver‐specific targets for treating liver diseases. Molecular Systems Biology 2017; 13(8) doi: 10.15252/msb.20177703
|
| 84 |
Miguel Jiménez-Pérez, Rocío González-Grande, Edith Omonte Guzmán, Víctor Amo Trillo, Juan Miguel Rodrigo López. Metabolic complications in liver transplant recipients. World Journal of Gastroenterology 2016; 22(28): 6416-6423 doi: 10.3748/wjg.v22.i28.6416
|
| 85 |
Milad Daneshi-Maskooni, Seyed Ali Keshavarz, Mostafa Qorbani, Siavash Mansouri, Seyed Moayed Alavian, Mahtab Badri-Fariman, Seyed Ali Jazayeri-Tehrani, Gity Sotoudeh. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial. BMC Complementary and Alternative Medicine 2019; 19(1) doi: 10.1186/s12906-019-2465-0
|
| 86 |
Manuel Romero-Gómez, Shira Zelber-Sagi, Michael Trenell. Treatment of NAFLD with diet, physical activity and exercise. Journal of Hepatology 2017; 67(4): 829 doi: 10.1016/j.jhep.2017.05.016
|
| 87 |
Aiman Obed, Abdalla Bashir, Anwar Jarrad. First right lobe living-donor hepatectomy after sleeve gastrectomy. BMC Surgery 2018; 18(1) doi: 10.1186/s12893-018-0366-7
|
| 88 |
Carmelo García‐Monzón, Javier Vargas‐Castrillón, José Luís Porrero, María Teresa Alonso, Oscar Bonachía, María José Castillo, Alberto Marcos, Esther Quirós, Beatriz Ramos, Carlos Sánchez‐Cabezudo, Sol Villar, Alicia Sáez, Javier Rodríguez de Cía, Elvira del Pozo, Lorena Vega‐Piris, Susana Soto‐Fernández, Oreste Lo Iacono, María Eugenia Miquilena‐Colina. Prevalence and risk factors for biopsy‐proven non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones. Liver International 2015; 35(8): 1983 doi: 10.1111/liv.12813
|
| 89 |
Natalia Balassiano Wajsbrot, Nathalie Carvalho Leite, Gil F Salles, Cristiane A Villela-Nogueira. Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring. World Journal of Gastroenterology 2022; 28(25): 2890-2899 doi: 10.3748/wjg.v28.i25.2890
|
| 90 |
Abdelrahman Mahmoud, Islam Mohamed, Mohamed Abuelazm, Ali Ashraf Salah Ahmed, Abdallah Saeed, Mahmoud Elshinawy, Omar Almaadawy, Basel Abdelazeem. Efficacy of orlistat in obese patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. Baylor University Medical Center Proceedings 2024; 37(4): 603 doi: 10.1080/08998280.2024.2335829
|
| 91 |
Yasar Colak, Ender M. Coskunpinar, Ebubekir Senates, Yasemin Musteri Oltulu, Ilhan Yaylim, Ozlem Kurnaz Gomleksiz, N. Ozan Tiryakioglu, Burcu Hasturk, Cumhur Gokhan Ekmekci, Hulya Yilmaz Aydogan. Assessment of the rs2645424 C/T single nucleotide polymorphisms in the FDFT1 gene, hepatic expression, and serum concentration of the FDFT in patients with nonalcoholic fatty liver disease. Meta Gene 2018; 18: 46 doi: 10.1016/j.mgene.2018.07.006
|